MedTrace Logo

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

NCT01293396 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-06-30

Study results available
· View outcomes & findings →

Summary

The aim of the study is to investigate meal-related treatment with either premixed Insulin Aspart 30, Aspart 70 and Aspart with regard to postprandial glucose, triglyceride and free fatty acids excursions after a standard breakfast and lunch.

Conditions

Interventions

DRUG

Insulin Aspart

Patients received insulin aspart before breakfast and before lunch.

DRUG

Insulin Aspart 30

Patients received biphasic insulin aspart 30 before breakfast and before lunch.

DRUG

Insulin Aspart 70

Patients received biphasic insulin aspart 70 before breakfast and before lunch.

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Harald Sourij, MD · Medical University of Graz, 8036 Graz, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-02-28
Completion
2011-03-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293396 on ClinicalTrials.gov